Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Changes in Shareholders??? Equity

v3.24.1.u1
Condensed Consolidated Statements of Changes in Shareholders’ Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2022   42,445,517    
Beginning balance at Dec. 31, 2022 $ 100,999 $ 424 $ 360,155 $ (259,580)
Increase (Decrease) in Stockholders' Equity        
Net loss (7,074)     (7,074)
Stock-based compensation 2,954   2,954  
Issuance of restricted and performance stock units (in shares)   238,719    
Issuance of restricted and performance stock units 0 $ 3 (3)  
Exercise of stock options and employee stock purchase plan (in shares)   125,758    
Exercise of stock options and employee stock purchase plan 634 $ 1 633  
Ending balance (in shares) at Mar. 31, 2023   42,809,994    
Ending balance at Mar. 31, 2023 $ 97,513 $ 428 363,739 (266,654)
Beginning balance (in shares) at Dec. 31, 2023 43,124,496 43,124,496    
Beginning balance at Dec. 31, 2023 $ 95,665 $ 431 376,530 (281,296)
Increase (Decrease) in Stockholders' Equity        
Net loss (6,635)      
Stock-based compensation 3,919   3,919  
Issuance of restricted and performance stock units (in shares)   539,233    
Issuance of restricted and performance stock units 0 $ 5 (5)  
Exercise of stock options and employee stock purchase plan (in shares)   24,000    
Exercise of stock options and employee stock purchase plan $ 207 $ 1 206  
Ending balance (in shares) at Mar. 31, 2024 43,687,729 43,687,729    
Ending balance at Mar. 31, 2024 $ 93,156 $ 437 $ 380,650 $ (287,931)